Climb Bio News

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Dec 20 16:22 ET

Climb Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(3.23%),Deep Track Biotechnology Master Fund, Ltd.(3.23%), etc.

Nov 14 09:31 ET

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 12 17:52 ET

Climb Bio | 3: Initial statement of beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 12 17:38 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Sep 20 21:57 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kaplan Brett

Aug 26 17:51 ET

Eliem Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Kaplan Brett

Aug 26 17:41 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Aug 16 16:28 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)

Aug 14 16:12 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 23 17:10 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 19 11:15 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 17 18:12 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 16 18:17 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 11 20:49 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 9 16:46 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Jul 3 14:46 ET

Eliem Therapeutics | D: Filing D

Jul 2 16:44 ET

Eliem Therapeutics | D: Filing D

Jul 2 16:43 ET

Eliem Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.85%),Deep Track Biotechnology Master Fund, Ltd.(5.85%), etc.

Jul 2 16:09 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Jul 1 21:34 ET